Clinical Trial Detail

NCT ID NCT02189174
Title Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

CLR457

Age Groups: adult

Additional content available in CKB BOOST